| Name | Cvs Pharmacy # 03675 |
|---|---|
| Organization Name | Holiday Cvs Llc |
| Location | 1 E Nine Mile Rd, Pensacola, Florida 32534 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (850) 475-1000 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
The biopharmaceutical company Antisense Pharma announced today that the US-American Food and Drug Administration (FDA) has issued an Investigational New Drug (IND)-authorisation for clinical studies with trabedersen for patients with high-grade glioma. This authorisation entitles the company to include US-American clinics both in the phase III study SAPPHIRE and in further studies.
Late-breaking results from the PROSPECT clinical trial shed new light on the types of vulnerable plaque that are most likely to cause sudden, unexpected adverse cardiac events, and on the ability to identify them through imaging techniques before they occur.
The Damon Runyon Cancer Research Foundation, a non-profit organization focused on supporting innovative early career researchers, named the first recipients of the Dale F. Frey Award for Breakthrough Scientists. This new award provides additional funding to scientists completing a prestigious Damon Runyon Fellowship Award who have greatly exceeded the Foundation's highest expectations and are most likely to make paradigm-shifting breakthroughs that transform the way we prevent, diagnose and treat cancer.
A new study released on the bioRxiv* server compared the antibodies produced in young patients with these three conditions against the two immunodominant coronavirus antigens, the spike and the nucleocapsid antigens.
› Verified 7 days ago
| NPI Number | 1831293752 |
| Organization Name | HOLIDAY CVS LLC |
| Doing Business As | CVS PHARMACY 03675 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 1 E Nine Mile Rd, Pensacola, FL 32534 |
| Phone Number | 850-475-1000 |
News Archive
The biopharmaceutical company Antisense Pharma announced today that the US-American Food and Drug Administration (FDA) has issued an Investigational New Drug (IND)-authorisation for clinical studies with trabedersen for patients with high-grade glioma. This authorisation entitles the company to include US-American clinics both in the phase III study SAPPHIRE and in further studies.
Late-breaking results from the PROSPECT clinical trial shed new light on the types of vulnerable plaque that are most likely to cause sudden, unexpected adverse cardiac events, and on the ability to identify them through imaging techniques before they occur.
The Damon Runyon Cancer Research Foundation, a non-profit organization focused on supporting innovative early career researchers, named the first recipients of the Dale F. Frey Award for Breakthrough Scientists. This new award provides additional funding to scientists completing a prestigious Damon Runyon Fellowship Award who have greatly exceeded the Foundation's highest expectations and are most likely to make paradigm-shifting breakthroughs that transform the way we prevent, diagnose and treat cancer.
A new study released on the bioRxiv* server compared the antibodies produced in young patients with these three conditions against the two immunodominant coronavirus antigens, the spike and the nucleocapsid antigens.
› Verified 7 days ago
News Archive
The biopharmaceutical company Antisense Pharma announced today that the US-American Food and Drug Administration (FDA) has issued an Investigational New Drug (IND)-authorisation for clinical studies with trabedersen for patients with high-grade glioma. This authorisation entitles the company to include US-American clinics both in the phase III study SAPPHIRE and in further studies.
Late-breaking results from the PROSPECT clinical trial shed new light on the types of vulnerable plaque that are most likely to cause sudden, unexpected adverse cardiac events, and on the ability to identify them through imaging techniques before they occur.
The Damon Runyon Cancer Research Foundation, a non-profit organization focused on supporting innovative early career researchers, named the first recipients of the Dale F. Frey Award for Breakthrough Scientists. This new award provides additional funding to scientists completing a prestigious Damon Runyon Fellowship Award who have greatly exceeded the Foundation's highest expectations and are most likely to make paradigm-shifting breakthroughs that transform the way we prevent, diagnose and treat cancer.
A new study released on the bioRxiv* server compared the antibodies produced in young patients with these three conditions against the two immunodominant coronavirus antigens, the spike and the nucleocapsid antigens.
› Verified 7 days ago
Apria Healthcare Llc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 33 Brent Ln 100, Pensacola, Florida 32503 Phone: (850) 433-7434 | |
Grace Medical, Inc. Type: Durable Medical Equipment & Medical Supplies Supplier Location: 3103 N 12th Ave, Pensacola, Florida 32503 Phone: (850) 476-0038 | |
Publix Pharmacy #1317 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 9251 University Pkwy, Pensacola, Florida 32514 Phone: (850) 473-5005 | |
Publix Pharmacy #1318 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 5998 Mobile Hwy, Pensacola, Florida 32526 Phone: (850) 941-8157 | |
Cvs Pharmacy # 03675 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1 E Nine Mile Rd, Pensacola, Florida 32534 Phone: (850) 475-1000 |